Search results
Results from the WOW.Com Content Network
Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware, [2] is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Retrieved from "https://en.wikipedia.org/w/index.php?title=Boston_Scientific_Corporation&oldid=19811070"
At the MGH Navy Yard site, there are eight large bore and five small bore MRI scanning bays used primarily for research, [2] including the high-gradient field Human Connectome Project scanner, a 7 Tesla magnet for human radiography, and a combined PET-MRI. The Martinos Center also served as the site for the development of magnetoencephalography ...
On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...
In a similar fashion, Siemens launched the Biograph mMR in 2010, the first scanner to completely combine MRI and PET technologies. [27] [28] Like PET-CT, PET-MR hybrid systems combine multiple technologies to provide a better image of the body, enabling better diagnoses, research, and treatment plans for patients. It combines precise images of ...
CPI was founded in February 1972 in Saint Paul, Minnesota.The first $50,000 capitalization for CPI was raised from a phone booth on the Minneapolis skyway system. [2] They began designing and testing their implantable cardiac pacemaker powered with a new longer-life lithium battery in 1971.
The next day, Boston Scientific increased their bid to $25 billion, followed the next day by Johnson & Johnson increasing their bid to $24.2 billion. It was not until January 17 that Boston Scientific produced a new offer of $27.2 billion ($80 per share), with the help of Abbott Laboratories. Abbott agreed to purchase $1.4 billion of Boston ...